Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy

Jurrien M. Ten Berg; Wout W. A. van den Broek

doi:10.1016/j.jcin.2023.02.008

Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy

Jurrien M. Ten Berg^*, Wout W. A. van den Broek

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	826-828
Number of pages	3
Journal	Jacc-Cardiovascular Interventions
Volume	16
Issue number	7
DOIs	https://doi.org/10.1016/j.jcin.2023.02.008
Publication status	Published - 10 Apr 2023

Keywords

antithrombotic therapy
coronary artery disease
personalized treatment
pharmacogenomics
PRASUGREL
OUTCOMES

Access to Document

10.1016/j.jcin.2023.02.008

Cite this

@article{dbcbd151e2e94d17bfd403c9cbfa5515,

title = "Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy",

keywords = "antithrombotic therapy, coronary artery disease, personalized treatment, pharmacogenomics, PRASUGREL, OUTCOMES",

author = "{Ten Berg}, {Jurrien M.} and {van den Broek}, {Wout W. A.}",

year = "2023",

month = apr,

day = "10",

doi = "10.1016/j.jcin.2023.02.008",

language = "English",

volume = "16",

pages = "826--828",

journal = "Jacc-Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Science",

number = "7",

}

TY - JOUR

T1 - Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy

AU - Ten Berg, Jurrien M.

AU - van den Broek, Wout W. A.

PY - 2023/4/10

Y1 - 2023/4/10

KW - antithrombotic therapy

KW - coronary artery disease

KW - personalized treatment

KW - pharmacogenomics

KW - PRASUGREL

KW - OUTCOMES

U2 - 10.1016/j.jcin.2023.02.008

DO - 10.1016/j.jcin.2023.02.008

M3 - Editorial

C2 - 37045503

SN - 1936-8798

VL - 16

SP - 826

EP - 828

JO - Jacc-Cardiovascular Interventions

JF - Jacc-Cardiovascular Interventions

IS - 7

ER -